Literature DB >> 22000992

The expression and role of CXC chemokines in colorectal cancer.

Hannelien Verbeke1, Sofie Struyf, Geneviève Laureys, Jo Van Damme.   

Abstract

Cancer is a life-threatening disease world-wide and colorectal cancer is the second common cause of cancer mortality. The interaction between tumor cells and stromal cells plays a crucial role in tumor initiation and progression and is partially mediated by chemokines. Chemokines predominantly participate in the chemoattraction of leukocytes to inflammatory sites. Nowadays, it is clear that CXC chemokines and their receptors (CXCR) may also modulate tumor behavior by several important mechanisms: regulation of angiogenesis, activation of a tumor-specific immune response by attracting leukocytes, stimulation of tumor cell proliferation and metastasis. Here, we review the expression and complex roles of CXC chemokines (CXCL1 to CXCL16) and their receptors (CXCR1 to CXCR6) in colorectal cancer. Overall, increased expression levels of CXC chemokines correlate with poor prognosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22000992     DOI: 10.1016/j.cytogfr.2011.09.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  60 in total

1.  Serum GROβ: a potential tumor-associated biomarker for colorectal cancer.

Authors:  Zhaoxu Zheng; Min Zheng; Jianjun Bi; Qiang Feng; Zhigang Yue; Yanqiu Zhou; Wanning Hu; Haizeng Zhang; Hongjun Gao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  Pharmacological approaches to regulate neutrophil activity.

Authors:  G R Tintinger; R Anderson; C Feldman
Journal:  Semin Immunopathol       Date:  2013-03-15       Impact factor: 9.623

3.  The role of interleukin-8 (CXCL8) and CXCR2 in acquired chemoresistance of human colorectal carcinoma cells HCT116.

Authors:  Daiva Dabkeviciene; Violeta Jonusiene; Vilmante Zitkute; Egle Zalyte; Pranas Grigaitis; Vida Kirveliene; Ausra Sasnauskiene
Journal:  Med Oncol       Date:  2015-10-30       Impact factor: 3.064

4.  Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.

Authors:  Ke-Qi Han; Xue-Qun He; Meng-Yu Ma; Xiao-Dong Guo; Xue-Min Zhang; Jie Chen; Hui Han; Wei-Wei Zhang; Quan-Gang Zhu; Hua Nian; Li-Jun Ma
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

5.  C-C motif chemokine receptors in gastric cancer.

Authors:  Hyewon Ryu; Seung Woo Baek; Ji Young Moon; In-Sook Jo; Nayoung Kim; Hyo Jin Lee
Journal:  Mol Clin Oncol       Date:  2017-10-27

Review 6.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  In vivo molecular mapping of the tumor microenvironment in an azoxymethane-treated mouse model of colon carcinogenesis.

Authors:  Sarah J Leung; Photini S Rice; Jennifer K Barton
Journal:  Lasers Surg Med       Date:  2014-12-09       Impact factor: 4.025

Review 8.  Tumor stroma as targets for cancer therapy.

Authors:  Jing Zhang; Jinsong Liu
Journal:  Pharmacol Ther       Date:  2012-10-12       Impact factor: 12.310

Review 9.  Management of resectable colorectal lung metastases.

Authors:  Sing Yu Moorcraft; George Ladas; Anne Bowcock; Ian Chau
Journal:  Clin Exp Metastasis       Date:  2015-12-10       Impact factor: 5.150

10.  Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.

Authors:  Michael A Casasanta; Christopher C Yoo; Barath Udayasuryan; Blake E Sanders; Ariana Umaña; Yao Zhang; Huaiyao Peng; Alison J Duncan; Yueying Wang; Liwu Li; Scott S Verbridge; Daniel J Slade
Journal:  Sci Signal       Date:  2020-07-21       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.